Chemomab Therapeutics Ltd. - stock earnings
CMMB Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -4.1 million USD | ? USD |
| 2023Q2 | -8.0 million USD | ? USD |
| 2023Q1 | -8.8 million USD | ? USD |
| 2022Q4 | -8.3 million USD | ? USD |
| 2022Q3 | -8.3 million USD | ? USD |
| 2022Q2 | -6.2 million USD | ? USD |
| 2022Q1 | -5.1 million USD | ? USD |
| 2021Q4 | -5.0 million USD | ? USD |
| 2021Q3 | -3.0 million USD | ? USD |
| 2021Q2 | -2.8 million USD | ? USD |
| 2021Q1 | -1.7 million USD | ? USD |
| 2020Q4 | -2.0 million USD | ? USD |
| 2020Q3 | -1.2 million USD | ? USD |
| 2020Q2 | -1.1 million USD | ? USD |
| 2020Q1 | -1.7 million USD | ? USD |
CMMB Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -27.6 million USD | ? USD |
| 2021 | -12.6 million USD | ? USD |
| 2020 | -5.9 million USD | ? USD |
| 2019 | 27.1 million USD | ? USD |
| 2018 | 13.3 million USD | ? USD |
| 2017 | -10.1 million USD | ? USD |
| 2012 | 24.2 million USD | ? USD |
CMMB
Price: $0.73
52 week price:
Earnings Per Share: -2.94 USD
P/E Ratio: -0.20
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 37000
Market Capitalization: 10.4 million